deltatrials
Completed NA INTERVENTIONAL 1-arm NCT01744418

Evaluation of the Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With ESRD

A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft for Use as a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease

Sponsor: FGK Clinical Research GmbH

Conditions End-stage Renal Disease Kidney Failure, Chronic
Interventions HAVG graft implantation
Updated 13 times since 2017 Last updated: Nov 11, 2024 Started: Nov 22, 2012 Primary completion: Dec 31, 2014 Completion: Mar 26, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01744418, this NA trial focuses on End-stage Renal Disease and Kidney Failure, Chronic and remains completed. Sponsored by FGK Clinical Research GmbH, it has been updated 13 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Feb 2019 · 5 months · monthly snapshot~Feb 2019 – ~Mar 2020 · 13 months · monthly snapshot~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Jan 2022 · 9 months · monthly snapshot~Jan 2022 – ~Sep 2022 · 8 months · monthly snapshot~Sep 2022 – ~Oct 2023 · 13 months · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – present · 19 months · monthly snapshot

Change History

13 versions recorded

  1. Dec 2024 — Present [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  2. Sep 2024 — Dec 2024 [monthly]

    Active Not Recruiting NA

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  4. Oct 2023 — Jul 2024 [monthly]

    Active Not Recruiting NA

  5. Sep 2022 — Oct 2023 [monthly]

    Active Not Recruiting NA

▶ Show 8 earlier versions

  1. Jan 2022 — Sep 2022 [monthly]

    Active Not Recruiting NA

  2. Apr 2021 — Jan 2022 [monthly]

    Active Not Recruiting NA

  3. Jan 2021 — Apr 2021 [monthly]

    Active Not Recruiting NA

  4. Mar 2020 — Jan 2021 [monthly]

    Active Not Recruiting NA

  5. Feb 2019 — Mar 2020 [monthly]

    Active Not Recruiting NA

  6. Sep 2018 — Feb 2019 [monthly]

    Active Not Recruiting NA

  7. Jun 2018 — Sep 2018 [monthly]

    Active Not Recruiting NA

  8. Jan 2017 — Jun 2018 [monthly]

    Active Not Recruiting NA

    First recorded

Nov 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • FGK Clinical Research GmbH
  • Humacyte, Inc.
Data source: Humacyte, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations